Back to Events

Traws Pharma Investor Event to discuss Bird Flu and COVID, the need for new antiviral drugs and the differentiated features of Traws Pharma’s oral small molecule product candidates

Traws Pharma
DATE: March 31, 2025
TIME: 10:00 AM EDT
LOCATION: Virtual

About The Event

Join Traws Pharma (Traws) for an investor event featuring Robert R. Redfield, MD, former Director of the U.S. Centers for Disease Control and Prevention (CDC) and Chief Medical Officer of Traws, and members of Traws management, who will discuss:

  • Tivoxavir Marboxil and Bird Flu: The significant public health risk and treatment landscape for H5N1 bird flu, data from Traws’ preclinical proof-of-concept and Phase 1 studies and next steps, including plans to interact with the FDA.
  • Ratutrelvir and COVID-19: Continued mortality, driving an ongoing need for improved care, data from Traws’ preclinical and Phase 1 studies, and next steps.

A live question and answer session will follow the formal presentation.